These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22574980)

  • 21. Time for a neurorestorative therapy in stroke.
    Jäkälä P; Jolkkonen J
    Expert Opin Biol Ther; 2012 Mar; 12(3):267-70. PubMed ID: 22251201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
    Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
    FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke.
    Liu R; Yuan H; Yuan F; Yang SH
    Neurol Res; 2012 May; 34(4):331-7. PubMed ID: 22643076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations and treatment strategies for the management of acute ischemic stroke.
    Segura T; Calleja S; Jordan J
    Expert Opin Pharmacother; 2008 May; 9(7):1071-85. PubMed ID: 18422467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuroprotective role of the brain opioid system in stroke injury.
    Vaidya B; Sifat AE; Karamyan VT; Abbruscato TJ
    Drug Discov Today; 2018 Jul; 23(7):1385-1395. PubMed ID: 29501910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Rev Neurol Dis; 2010; 7 Suppl 1():S14-21. PubMed ID: 20410866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm?
    Mowla A; Singh K; Mehla S; Ahmed MK; Shirani P; Kamal H; Krishna C; Sawyer RN; Ching M; Siddiqui AH; Levy EI; Snyder KV; Crumlish A; Hopkins LN
    Int J Stroke; 2015 Oct; 10 Suppl A100():113-8. PubMed ID: 26377963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia.
    Zhang L; Zhang ZG; Buller B; Jiang J; Jiang Y; Zhao D; Liu X; Morris D; Chopp M
    Stroke; 2010 May; 41(5):1001-7. PubMed ID: 20203318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Combination Therapy with Neuroprotective and Vasoprotective Agents on Cerebral Ischemia.
    Yang J; Yang B; Xiu B; Qi J; Liu H
    Can J Neurol Sci; 2018 May; 45(3):325-331. PubMed ID: 29756589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke research at a crossroad: asking the brain for directions.
    Iadecola C; Anrather J
    Nat Neurosci; 2011 Oct; 14(11):1363-8. PubMed ID: 22030546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection for ischaemic stroke: current status and challenges.
    Moretti A; Ferrari F; Villa RF
    Pharmacol Ther; 2015 Feb; 146():23-34. PubMed ID: 25196155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemic stroke intervention requires mixed cellular protection of the penumbra.
    Barone FC
    Curr Opin Investig Drugs; 2009 Mar; 10(3):220-3. PubMed ID: 19333878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.
    Fukuta T; Ishii T; Asai T; Oku N
    Biol Pharm Bull; 2019; 42(3):319-326. PubMed ID: 30828062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment.
    Knecht T; Story J; Liu J; Davis W; Borlongan CV; Dela Peña IC
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
    Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotherapies in stroke.
    Detante O; Jaillard A; Moisan A; Barbieux M; Favre IM; Garambois K; Hommel M; Remy C
    Rev Neurol (Paris); 2014 Dec; 170(12):779-98. PubMed ID: 25459115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developments in Neurovascular Diseases and Treatments.
    Starke RM; Monteith SJ; Southerland AM; Crowley RW; Chalouhi N; Ding D; Hasan DM; Dumont AS
    ScientificWorldJournal; 2015; 2015():608607. PubMed ID: 26417611
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroprotective therapy for the treatment of acute ischemic stroke].
    Naritomi H
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1060-3. PubMed ID: 12235795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.